Medigen Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Nov '24 Nov 20, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	4,806	6,243	4,685	7,999	8,228	8,612	Upgrade
Market Cap Growth	13.70%	33.24%	-41.43%	-2.78%	-4.46%	37.85%	Upgrade
Enterprise Value	6,762	8,430	7,328	10,273	10,336	10,698	Upgrade
Last Close Price	34.50	44.80	33.60	57.40	59.20	62.10	Upgrade
PS Ratio	3.41	5.39	4.44	2.04	13.37	15.59	Upgrade
PB Ratio	2.91	1.25	0.72	1.24	1.83	3.21	Upgrade
P/TBV Ratio	3.40	4.20	2.25	3.52	4.96	7.30	Upgrade
P/FCF Ratio	-	-	-	21.32	-	-	Upgrade
P/OCF Ratio	-	-	-	15.44	-	-	Upgrade
EV/Sales Ratio	4.79	7.28	6.94	2.62	16.79	19.37	Upgrade
EV/EBITDA Ratio	-	-	-	10.62	-	-	Upgrade
EV/EBIT Ratio	-	-	-	13.17	-	-	Upgrade
EV/FCF Ratio	-39.14	-	-	27.38	-	-	Upgrade
Debt / Equity Ratio	0.19	0.57	0.43	0.15	0.26	0.62	Upgrade
Debt / EBITDA Ratio	-	-	-	1.02	-	-	Upgrade
Debt / FCF Ratio	-	-	-	2.64	-	-	Upgrade
Asset Turnover	0.18	0.13	0.12	0.55	0.11	0.12	Upgrade
Inventory Turnover	0.75	0.87	1.34	2.55	1.53	2.23	Upgrade
Quick Ratio	3.24	1.81	5.32	3.60	2.72	1.15	Upgrade
Current Ratio	4.07	2.05	6.40	4.62	3.24	1.41	Upgrade
Return on Equity (ROE)	-16.55%	-25.64%	-29.95%	19.60%	-23.59%	-29.38%	Upgrade
Return on Assets (ROA)	-5.66%	-8.33%	-11.46%	6.79%	-10.38%	-10.11%	Upgrade
Return on Capital (ROIC)	-6.14%	-9.01%	-12.50%	7.44%	-11.36%	-11.00%	Upgrade
Earnings Yield	-8.56%	-8.99%	-14.43%	-0.66%	-4.11%	-2.97%	Upgrade
FCF Yield	-3.59%	-8.68%	-27.46%	4.69%	-9.97%	-7.76%	Upgrade
Buyback Yield / Dilution	-0.50%	-0.16%	-0.11%	0.01%	-0.22%	-	Upgrade
Total Shareholder Return	-0.50%	-0.16%	-0.11%	0.01%	-0.22%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.